Remove 2013 Remove Compounding Remove Vaccines
article thumbnail

Preventing fungal contamination in pharmaceuticals

European Pharmaceutical Review

In a review on fungal-contaminated compounded pharmaceuticals and medical devices, researchers have described how the contamination of these products can be due to breaches in sterile compounding procedures. Ahmed et al. According to the authors, these were linked to 55 fatal cases of fungal meningitis.

article thumbnail

Pharmaceutical microbiology: key developments 2022

European Pharmaceutical Review

MALDI-TOF works on the basis of the ionisation of chemical compounds and measurements of their mass to charge (m/z) ratio. The safety and efficacy of mRNA vaccines should be a game changer and is the likely solution to antibiotic-resistant microorganisms and emerging viral pathogens.”

Vaccines 128
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

High biologics demand spurs need for greater contract manufacturing

Pharmaceutical Technology

Demand for biologics, including vaccines, is at an all-time high, in the post-Covid era. The US accounts for almost half of all biotechnology patents filed worldwide from 1999 to 2013. There are fewer sites for cell and gene therapies and vaccines – 90 companies with 127 facilities, as per GlobalData figures.

article thumbnail

Contamination Trends & Proposed Solutions

ISPE

5 , 8 Compounding pharmacies were commonly mentioned as sources of microbial cross-contamination, especially in the US. 9 , 15 This has led to compounding pharmacies completing high-volume activities such as mass repackaging, thereby increasing the risk of cross-contamination. million vials, 26 had to be recalled and destroyed.